Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors
ChemMedChem · 17.05.2024 · 19 (10)
DOI: 10.1002/cmdc.202400004 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 04.03.2024. Verfasst von Ehab S Taher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical and Dental Sciences, Faculty of Dentistry, Zarqa University, Zarqa, 13110, Jordan. Hauptthemen laut MEDLINE: Benzenesulfonamides, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase IX, Carbonic Anhydrases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Deanship of Scientific Research at Shaqra University.
Abstract (Originalsprache)
A new series of tetrasubstituted imidazole carrying sulfonamide as zinc‐anchoring group has been designed. The structures of the synthesized derivatives 5 a – l have been confirmed by spectroscopic analysis. These compounds incorporate an ethylenic spacer between the benzenesulfonamide and the rest of the trisubstituted imidazole moiety and were tested as inhibitors of carbonic anhydrases and for in ‐ vitro cytotoxicity. Most of them act as effective inhibitors of the tumor‐linked CA isoforms IX and XII, in nanomolar range. Also, different compounds have shown selectivity in comparable with the standard acetazolamide. Our IBS 5 d , 5 g , and 5 l (with Ki: 10.1, 19.4, 19.8 nM against hCA IX and 47, 45, 20 nM against hCA IX) showed the best inhibitory profile. In‐vitro screening of all derivatives against a full sixty‐cell‐lined from NCI at a single dose of 10 μM offered growth inhibition of up to 45 %. Compound 5 b has been identified with the most potent cytotoxic activity and broad spectrum. Docking studies have also been implemented and were also in accordance with the biological outcomes. Our SAR analysis has interestingly proposed efficient tumor‐related hCAs IX/XII suppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical and Dental Sciences, Faculty of Dentistry, Zarqa University, Zarqa, 13110, Jordan.
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Al-Azhar University, Asyut, 71524, Assiut, Egypt.
- National Center for Natural Products Research, School of Pharmacy, Mississippi University, Mississippi, MS 38677, USA.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Asyut, 71524, Assiut, Egypt.
- Pharmaceutical Chemistry Department, Collage of Pharmaceutical Science and Drug Manufacturing, Misr University for Science and Technology, P.O. 77, 6th of October City, Giza, Egypt.
- Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Polo Scientifico, Via U. Schiff 6, 50019, Sesto Fiorentino, Firenze, Italy.
ORCID-Profile: Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Förderung
- Deanship of Scientific Research at Shaqra University
Zitieren
APA
Taher, E. S., Marzouk, A. A., Abd-Allah, W. H., Giovannuzzi, S., Ibrahim, T. S., Supuran, C. T., El Hamd, M. A., & El-Behairy, M. F. (2024). Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem, 19(10). https://doi.org/10.1002/cmdc.202400004
Vancouver
Taher ES, Marzouk AA, Abd-Allah WH, Giovannuzzi S, Ibrahim TS, Supuran CT, et al. Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem. 2024;19(10). doi:10.1002/cmdc.202400004
BibTeX
@article{Taher2024,
author = {Taher, Ehab S and Marzouk, Adel A and Abd-Allah, Walaa Hamada and Giovannuzzi, Simone and Ibrahim, Tarek S and Supuran, Claudiu T and El Hamd, Mohamed A and El-Behairy, Mohammed Farrag},
title = {Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors},
journal = {ChemMedChem},
year = {2024},
volume = {19},
number = {10},
doi = {10.1002/cmdc.202400004}
}
EUVIMED